Cite
HARVARD Citation
Tang, M. et al. (2018). Review article: nonclinical and clinical pharmacology, pharmacokinetics and pharmacodynamics of etrolizumab, an anti‐β7 integrin therapy for inflammatory bowel disease. Alimentary pharmacology & therapeutics. 47 (11), pp. 1440-1452. [Online].